Found 2675 matching trials
MB-CART20.1 Lymphoma
PHASE1This trial is a phase I/II trial to assess safety, dose finding and feasibi...
Location
University Hospital of Cologne - Clinic for Internal Medicine I
MK-2206, Paclitaxel and Trastuzumab in Treating Patients With HER2-overexpressing Solid Tumor Malignancies
PHASE1The purpose of this study is to test the safety and safest highest dose of ...
Location
University of California, San Francisco
Study of the Selective PI3K-Beta Inhibitor GSK2636771 in Combination With Pembrolizumab in Patients With Metastatic Melanoma and PTEN Loss
PHASE1The goal of this clinical research study is to learn if GSK2636771 given in...
Location
University of Texas MD Anderson Cancer Center
NAC to Prevent Cisplatin-induced Hearing Loss
PHASE1Cisplatin is a key chemotherapy agent for the treatment of multiple childho...
Location
Childrens Hospital Los Angeles
Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
PHASE1Hematopoietic stem cell transplantation can cure patients with blood cancer...
Location
University of Florida
AvidinOX + [177Lu]DOTA-biotin (or 177Lu-ST2210) Complex in Patients With Liver Metastases From Colorectal Cancer
PHASE1The purpose of the study is to assess a new treatment for patients with liv...
Location
Allgemeines Krankenhaus Wien
Sabril for Complex Partial Seizures in Adult Tolerability Study (TS) Patients
PHASE4This is an open-label, phase 4 study to examine the safety and efficacy of ...
Location
University of Pennsylvania
Safety Study of AP24534 to Treat Chronic Myelogenous Leukemia (CML) and Other Hematological Malignancies
PHASE1The purpose of this study is to determine the maximum tolerated dose or a r...
Location
ARIAD Investigational Site #075
Study of Combination Therapy With Mogamulizumab (KW-0761) and Nivolumab (ONO-4538/BMS-936558) in Subjects With Advanced Solid Tumors
PHASE1The purpose of this study is to characterize the safety and tolerability an...
Location
Multiple Locations
Study of SNX281 in Subjects With Advanced Solid Tumors and Lymphoma
PHASE1This clinical trial is evaluating a drug called SNX281 given by itself and ...
Location
Sarah Cannon Research Institute at HealthONE